The decrease of CSF MMP9 in AD suggest that resveratrol may mitigate inflammatory responses in the brain by reducing the permeability of CNS and lower infiltration of leukocytes and other inflammatory agents into the brain. Here, MMP9 is linked to Alzheimer disease.